NewsNovo CEO signals M&A opportunities to strengthen drug pipeline Posted on September 22, 2026 by budd87309@gmail.com Novo CEO Mike Doustdar told CNBC that it is considering M&A opportunities as it faces growing competition in the weight-loss market. budd87309@gmail.com Trump to press Zelenskyy for energy truce, says Russia has ‘lost control’ of oil due to Ukraine war Protests as ICE agent shoots and wounds Venezuelan DoorDash driver in Texas – BBC
